128 related articles for article (PubMed ID: 8661226)
1. Actin disruption inhibits bombesin stimulation of focal adhesion kinase (pp125FAK) in prostate carcinoma.
Duncan MD; Harmon JW; Duncan LK
J Surg Res; 1996 Jun; 63(1):359-63. PubMed ID: 8661226
[TBL] [Abstract][Full Text] [Related]
2. Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins.
Aprikian AG; Tremblay L; Han K; Chevalier S
Int J Cancer; 1997 Jul; 72(3):498-504. PubMed ID: 9247295
[TBL] [Abstract][Full Text] [Related]
3. Neuromedin B receptor activation causes tyrosine phosphorylation of p125FAK by a phospholipase C independent mechanism which requires p21rho and integrity of the actin cytoskeleton.
Tsuda T; Kusui T; Jensen RT
Biochemistry; 1997 Dec; 36(51):16328-37. PubMed ID: 9405068
[TBL] [Abstract][Full Text] [Related]
4. Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway.
Seufferlein T; Rozengurt E
J Biol Chem; 1995 Oct; 270(41):24343-51. PubMed ID: 7592646
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin does not require extracellular signal-regulated kinase activation in Swiss 3T3 cells stimulated by bombesin or platelet-derived growth factor.
Leopoldt D; Yee HF; Saab S; Rozengurt E
J Cell Physiol; 2000 May; 183(2):208-20. PubMed ID: 10737896
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neuropeptide-stimulated tyrosine phosphorylation and tyrosine kinase activity stimulates apoptosis in small cell lung cancer cells.
Tallett A; Chilvers ER; Hannah S; Dransfield I; Lawson MF; Haslett C; Sethi T
Cancer Res; 1996 Sep; 56(18):4255-63. PubMed ID: 8797601
[TBL] [Abstract][Full Text] [Related]
7. Bombesin and gastrin releasing peptide increase tyrosine phosphorylation of focal adhesion kinase and paxillin in non-small cell lung cancer cells.
Leyton J; Garcia-Marin LJ; Tapia JA; Jensen RT; Moody TW
Cancer Lett; 2001 Jan; 162(1):87-95. PubMed ID: 11121866
[TBL] [Abstract][Full Text] [Related]
8. Bombesin stimulation of p125 focal adhesion kinase tyrosine phosphorylation. Role of protein kinase C, Ca2+ mobilization, and the actin cytoskeleton.
Sinnett-Smith J; Zachary I; Valverde AM; Rozengurt E
J Biol Chem; 1993 Jul; 268(19):14261-8. PubMed ID: 8314789
[TBL] [Abstract][Full Text] [Related]
9. Calyculin-A induces focal adhesion assembly and tyrosine phosphorylation of p125(Fak), p130(Cas), and paxillin in Swiss 3T3 cells.
Leopoldt D; Yee HF; Rozengurt E
J Cell Physiol; 2001 Jul; 188(1):106-19. PubMed ID: 11382927
[TBL] [Abstract][Full Text] [Related]
10. Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells.
Salazar EP; Rozengurt E
J Biol Chem; 1999 Oct; 274(40):28371-8. PubMed ID: 10497197
[TBL] [Abstract][Full Text] [Related]
11. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton.
Senderowicz AM; Kaur G; Sainz E; Laing C; Inman WD; Rodríguez J; Crews P; Malspeis L; Grever MR; Sausville EA
J Natl Cancer Inst; 1995 Jan; 87(1):46-51. PubMed ID: 7666463
[TBL] [Abstract][Full Text] [Related]
12. Bombesin, vasopressin, and endothelin stimulation of tyrosine phosphorylation in Swiss 3T3 cells. Identification of a novel tyrosine kinase as a major substrate.
Zachary I; Sinnett-Smith J; Rozengurt E
J Biol Chem; 1992 Sep; 267(27):19031-4. PubMed ID: 1382065
[TBL] [Abstract][Full Text] [Related]
13. Bombesin, vasopressin, lysophosphatidic acid, and sphingosylphosphorylcholine induce focal adhesion kinase activation in intact Swiss 3T3 cells.
Rodríguez-Fernández JL; Rozengurt E
J Biol Chem; 1998 Jul; 273(30):19321-8. PubMed ID: 9668122
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin-stimulated tyrosine phosphorylation of p125FAK and paxillin is mediated by phospholipase C-dependent and -independent mechanisms and requires the integrity of the actin cytoskeleton and participation of p21rho.
García LJ; Rosado JA; González A; Jensen RT
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):461-72. PubMed ID: 9359417
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton.
Koukouritaki SB; Gravanis A; Stournaras C
Mol Med; 1999 Nov; 5(11):731-42. PubMed ID: 10656875
[TBL] [Abstract][Full Text] [Related]
16. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling.
Sumitomo M; Shen R; Walburg M; Dai J; Geng Y; Navarro D; Boileau G; Papandreou CN; Giancotti FG; Knudsen B; Nanus DM
J Clin Invest; 2000 Dec; 106(11):1399-407. PubMed ID: 11104793
[TBL] [Abstract][Full Text] [Related]
17. Bombesin, bradykinin, vasopressin, and phorbol esters rapidly and transiently activate Src family tyrosine kinases in Swiss 3T3 cells. Dissociation from tyrosine phosphorylation of p125 focal adhesion kinase.
Rodríguez-Fernández JL; Rozengurt E
J Biol Chem; 1996 Nov; 271(44):27895-901. PubMed ID: 8910389
[TBL] [Abstract][Full Text] [Related]
18. Y-27632, an inhibitor of Rho-associated kinases, prevents tyrosine phosphorylation of focal adhesion kinase and paxillin induced by bombesin: dissociation from tyrosine phosphorylation of p130(CAS).
Sinnett-Smith J; Lunn JA; Leopoldt D; Rozengurt E
Exp Cell Res; 2001 Jun; 266(2):292-302. PubMed ID: 11399057
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase is required for bombesin-induced prostate cancer cell motility.
Lacoste J; Aprikian AG; Chevalier S
Mol Cell Endocrinol; 2005 May; 235(1-2):51-61. PubMed ID: 15866427
[TBL] [Abstract][Full Text] [Related]
20. Correlations between the expression, phosphotyrosine content and enzymatic activity of focal adhesion kinase, pp125FAK, in tumor and nontransformed cells.
Withers BE; Hanks SK; Fry DW
Cancer Biochem Biophys; 1996 Apr; 15(3):127-39. PubMed ID: 8937737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
